Form 8-K - Current report:
SEC Accession No. 0001493152-24-049133
Filing Date
2024-12-06
Accepted
2024-12-06 17:15:20
Documents
16
Period of Report
2024-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51105
2 ex10-1.htm EX-10.1 89309
3 ex10-1_001.jpg GRAPHIC 42774
4 ex10-1_002.jpg GRAPHIC 12723
  Complete submission text file 0001493152-24-049133.txt   410521

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mgrx-20241202.xsd EX-101.SCH 3033
6 XBRL LABEL FILE mgrx-20241202_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE mgrx-20241202_pre.xml EX-101.PRE 24177
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241533198
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)